期刊文献+

复发性耐药性妇科恶性肿瘤治疗策略 被引量:5

Treatment strategy for recurrent drug-resistant gynecologic malignant tumor
原文传递
导出
摘要 妇科恶性肿瘤发生于女性生殖系统,最常见的有子宫颈癌、卵巢癌、子宫内膜癌、滋养细胞肿瘤等。其中上皮性卵巢癌耐药及复发的发生率最高,尽管手术理念不断更新和手术技巧不断改进,晚期上皮性卵巢癌满意的初次手术率除个别报道可达90%外[1],大多报道在3.9%~62.9%[2],不满意的初次手术为耐药及复发埋下了隐患。
作者 王新宇 谢幸
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2015年第3期195-197,共3页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 耐药 复发 妇科恶性肿瘤 resistance recurrence gynecologic malignant tumor
  • 相关文献

参考文献15

  • 1Chi DS, Musa F, Dan F, et al. An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadju-vant chemotherapy (NACT) [J]. Gynecol Oncol, 2012, 124(1): 10-14.
  • 2du Bois A, Marth C, Pfisterer J, et al. Neoadjuvant chemotherapy cannot be regarded as adequate routine therapy strategy of ad- vanced ovarian cancer [J]. Int J Gynecol Cancer, 2012, 22(2): 182-185.
  • 3Ozols RF, Bundy BN, Greet BE, et al. Phase III trial of carboplat- in and paclitaxel compared with cisplatin and paclitaxe| in pa- tients with optimally resected stage III ovarian cancer: a gyneco- logic oncology group study [J]. J Clin Oncol, 2003,21: 3194- 3200.
  • 4Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irra- diation alone [J ].Cancer, 1992,69:2796-2806.
  • 5Marchiol6 P, Bu6nerd A, Benchaib M, et al. Clinical significance of lymphovascular space involvement and lymph node microme- tastases in early-stage cervical cancer: a retrospective case-con- trol surgicopathological study [J]. Gyneeol Oncol, 2005, 97(3): 727-732.
  • 6Grisaru DA, Covens A, Franssen E, et al. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-1B 1-2 cervical carcinoma [ J 1. Cancer, 2003,97 (8):1904-1908.
  • 7Fung-Kee-Fung M, Dodge J, Elit L, et al. Follow-up after prima- ry therapy for endometrial cancer: a systematic review [J ]. Gyne- col Oncol, 2006,101:520-529.
  • 8Smaniotto D, D'Agostino G, Luzi S, et al. Concurrent 5-fluoro- uracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome [J ]. Tumori, 2005,91 (4):295-301.
  • 9Rahaman J, Steiner N, Hayes MP, et al. Chemotherapy for gyne- cologic cancers [ J 1. Mount Sinai J Med, 2009, 76:577-588.
  • 10Blackledge G, Lawton F, Redman C, et al. Response of patients in phase II studies of chemotherapy in ovarian cancer: implica- tions for patient treatment and the design of phase II trials [Jl. Br J Cancer, 1989,59:650-653.

同被引文献40

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部